Laman UtamaTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Tutup sebelumnya
₹362.00
Julat hari
₹352.90 - ₹367.65
Julat tahun
₹219.57 - ₹536.67
Permodalan pasaran
58.08B INR
Bilangan Purata
372.64K
Nisbah P/E
41.94
Hasil dividen
1.60%
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.96B | 17.85% |
Perbelanjaan pengendalian | 763.70J | 25.20% |
Pendapatan bersih | 290.10J | 51.81% |
Margin untung bersih | 14.84 | 28.82% |
Pendapatan bagi setiap syer | 2.11 | 78.20% |
EBITDA | 477.75J | 39.42% |
Kadar cukai berkesan | 20.74% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.92B | 39.87% |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | 5.34B | — |
Syer tertunggak | 159.16J | — |
Harga kepada buku | 10.77 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 16.20% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 290.10J | 51.81% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Diasaskan
1996
Ibu pejabat
Tapak web
Pekerja
1,822
